Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKD
利福昔明疗法降低 CKD 患者肠道心血管毒素和炎症的随机、安慰剂对照试验
期刊:Kidney360
影响因子:3.2
doi:10.34067/kid.0003942020
Cassandra Kimber, Shiqin Zhang, Cassandra Johnson, Raymond E West 3rd, Alexander J Prokopienko, Jonathan D Mahnken, Alan S Yu, Andrew N Hoofnagle, Diana Ir, Charles E Robertson, Makoto Miyazaki, Michel Chonchol, Anna Jovanovich, Bryan Kestenbaum, Daniel N Frank, Thomas D Nolin, Jason R Stubbs
心血管
肠炎
Immunology/Inflammation